Under such a model is where our results may be the most relevant, as GLUT4 and its associated trafficking genes (e.g., TBC1D4/AS160) are significantly downregulated in the muscle of dermatomyositis patients presenting with exaggerated interferon signatures. This evidence concerns the gene TBC1D4 and dermatomyositis.